首页 > 最新文献

Health Policy and Technology最新文献

英文 中文
Facilitating acceptance, trust, and ethical integration of socially assistive robots among nurses: A quasi-experimental study 促进护士对社会辅助机器人的接受、信任和伦理整合:一项准实验研究
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-06-01 Epub Date: 2025-05-20 DOI: 10.1016/j.hlpt.2025.101034
Izidor Mlakar (Dr.) , Igor Robert Roj , Vojko Flis (Dr.) , Valentino Šafran , Urška Smrke (Dr.) , Nejc Plohl (Dr.)
Objectives: To evaluate the impact of different types of demonstrations (no demonstration, video demonstration, and face-to-face demonstration) on nurses’ acceptance, trust, and ethical considerations regarding socially assistive robots.
Methods: The study employed a quasi-experimental design involving 312 nurses: 201 with no exposure to socially assistive robots, 97 exposed via video demonstrations, and 14 exposed through live face-to-face demonstrations in a hospital room. Participants completed self-report measures assessing their perceptions of ethical acceptability, trust, and acceptance of socially assistive robots.
Results: Participants exposed to any kind of demonstration reported significantly higher perceptions of ethical acceptability compared to those with no exposure. Among demonstration types, live face-to-face demonstrations resulted in higher overall ethical acceptability, satisfaction, and acceptance compared to video demonstrations.
Conclusions: Demonstrations, particularly face-to-face interactions, play a crucial role in fostering ethical acceptability and overall acceptance of socially assistive robots. These findings highlight the importance of incorporating live demonstrations in strategies to improve healthcare professionals’ trust and acceptance of robotic technology.
目的:评估不同类型的演示(无演示、视频演示和面对面演示)对护士对社交辅助机器人的接受度、信任度和伦理考虑的影响。方法:本研究采用准实验设计,涉及312名护士:201名未接触社交辅助机器人,97名通过视频演示,14名通过病房现场面对面演示。参与者完成了自我报告测量,评估他们对社会辅助机器人的道德可接受性、信任和接受度的看法。结果:与没有接触的参与者相比,接触任何形式的演示的参与者报告了明显更高的道德可接受性观念。在演示类型中,与视频演示相比,现场面对面演示的总体道德可接受性、满意度和接受度更高。结论:演示,特别是面对面的互动,在促进社会辅助机器人的道德接受度和整体接受度方面发挥着至关重要的作用。这些发现强调了将现场演示纳入提高医疗保健专业人员对机器人技术的信任和接受度的战略的重要性。
{"title":"Facilitating acceptance, trust, and ethical integration of socially assistive robots among nurses: A quasi-experimental study","authors":"Izidor Mlakar (Dr.) ,&nbsp;Igor Robert Roj ,&nbsp;Vojko Flis (Dr.) ,&nbsp;Valentino Šafran ,&nbsp;Urška Smrke (Dr.) ,&nbsp;Nejc Plohl (Dr.)","doi":"10.1016/j.hlpt.2025.101034","DOIUrl":"10.1016/j.hlpt.2025.101034","url":null,"abstract":"<div><div>Objectives: To evaluate the impact of different types of demonstrations (no demonstration, video demonstration, and face-to-face demonstration) on nurses’ acceptance, trust, and ethical considerations regarding socially assistive robots.</div><div>Methods: The study employed a quasi-experimental design involving 312 nurses: 201 with no exposure to socially assistive robots, 97 exposed via video demonstrations, and 14 exposed through live face-to-face demonstrations in a hospital room. Participants completed self-report measures assessing their perceptions of ethical acceptability, trust, and acceptance of socially assistive robots.</div><div>Results: Participants exposed to any kind of demonstration reported significantly higher perceptions of ethical acceptability compared to those with no exposure. Among demonstration types, live face-to-face demonstrations resulted in higher overall ethical acceptability, satisfaction, and acceptance compared to video demonstrations.</div><div>Conclusions: Demonstrations, particularly face-to-face interactions, play a crucial role in fostering ethical acceptability and overall acceptance of socially assistive robots. These findings highlight the importance of incorporating live demonstrations in strategies to improve healthcare professionals’ trust and acceptance of robotic technology.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 3","pages":"Article 101034"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144137686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Volume-cost relationship in Pancreatic Surgery: A scoping review 胰腺手术的数量-成本关系:范围综述
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-06-01 Epub Date: 2025-04-29 DOI: 10.1016/j.hlpt.2025.101020
Nashmil Ghadimi , Alireza Olyaeemanesh , Ali Akbar Fazaeli , Rajabali Daroudi , Sara Kaveh

Objectives

To synthesize evidence on the volume-cost relationship (VCR) in pancreatic surgery, focusing on the impact of hospital and surgeon volumes on economic indicators.

Methods

A scoping review was conducted using PubMed, Web of Science, and Scopus to identify studies published from inception to November 30, 2024, to ensure a comprehensive and unbiased review of all relevant studies. The PRISMA-ScR framework guided data extraction, focusing on hospital and surgeon volumes in relation to costs, length of stay (LOS), resource utilization, and readmissions. The metrics included cost definitions, volume thresholds, and economic indicators. Studies that analyzed the economic impact of centralization in pancreatic surgery were included.

Results

Twenty-two studies (1996–2024), primarily from the United States, were included. Pancreaticoduodenectomy was the most studied procedure. High-volume Hospitals (HVHs) consistently demonstrated reduced costs, shorter LOS, lower resource utilization, and higher discharge-to-home rates compared to low-volume hospitals (LVHs). Cost reductions were attributed to enhanced efficiency and fewer complications. However, there was significant variability in volume thresholds and limited use of cost-effectiveness analyses (CEAs). Few studies addressed broader societal costs, such as productivity losses or caregiver burden.

Conclusions

Centralizing pancreatic surgeries in HVHs offers clear economic impact through improved efficiency and outcomes. Addressing gaps in standardized volume definitions, incorporating socioeconomic factors, and expanding CEAs are critical for optimizing resource allocation and ensuring equitable and cost-effective care. Future research should focus on these areas to inform better health policies.
目的综合胰腺手术中数量-成本关系(VCR)的证据,重点研究医院和外科医生数量对经济指标的影响。方法使用PubMed、Web of Science和Scopus进行范围审查,以确定从成立到2024年11月30日发表的研究,以确保对所有相关研究进行全面和公正的审查。PRISMA-ScR框架指导数据提取,重点关注与成本、住院时间(LOS)、资源利用和再入院相关的医院和外科医生数量。度量标准包括成本定义、容量阈值和经济指标。研究分析了胰腺手术中心化的经济影响。结果纳入主要来自美国的22项研究(1996-2024)。胰十二指肠切除术是研究最多的手术。与小容量医院(LVHs)相比,大容量医院(HVHs)一贯表现出更低的成本、更短的LOS、更低的资源利用率和更高的出院回家率。成本的降低归功于效率的提高和并发症的减少。然而,在容量阈值方面存在显著的可变性,成本效益分析(cea)的使用有限。很少有研究涉及更广泛的社会成本,如生产力损失或照顾者负担。结论集中式胰腺手术在HVHs中通过提高效率和预后具有明显的经济效益。解决标准化数量定义中的差距、纳入社会经济因素和扩大cea对于优化资源分配和确保公平和具有成本效益的护理至关重要。未来的研究应侧重于这些领域,以便为更好的卫生政策提供信息。
{"title":"Volume-cost relationship in Pancreatic Surgery: A scoping review","authors":"Nashmil Ghadimi ,&nbsp;Alireza Olyaeemanesh ,&nbsp;Ali Akbar Fazaeli ,&nbsp;Rajabali Daroudi ,&nbsp;Sara Kaveh","doi":"10.1016/j.hlpt.2025.101020","DOIUrl":"10.1016/j.hlpt.2025.101020","url":null,"abstract":"<div><h3>Objectives</h3><div>To synthesize evidence on the volume-cost relationship (VCR) in pancreatic surgery, focusing on the impact of hospital and surgeon volumes on economic indicators.</div></div><div><h3>Methods</h3><div>A scoping review was conducted using PubMed, Web of Science, and Scopus to identify studies published from inception to November 30, 2024, to ensure a comprehensive and unbiased review of all relevant studies. The PRISMA-ScR framework guided data extraction, focusing on hospital and surgeon volumes in relation to costs, length of stay (LOS), resource utilization, and readmissions. The metrics included cost definitions, volume thresholds, and economic indicators. Studies that analyzed the economic impact of centralization in pancreatic surgery were included.</div></div><div><h3>Results</h3><div>Twenty-two studies (1996–2024), primarily from the United States, were included. Pancreaticoduodenectomy was the most studied procedure. High-volume Hospitals (HVHs) consistently demonstrated reduced costs, shorter LOS, lower resource utilization, and higher discharge-to-home rates compared to low-volume hospitals (LVHs). Cost reductions were attributed to enhanced efficiency and fewer complications. However, there was significant variability in volume thresholds and limited use of cost-effectiveness analyses (CEAs). Few studies addressed broader societal costs, such as productivity losses or caregiver burden.</div></div><div><h3>Conclusions</h3><div>Centralizing pancreatic surgeries in HVHs offers clear economic impact through improved efficiency and outcomes. Addressing gaps in standardized volume definitions, incorporating socioeconomic factors, and expanding CEAs are critical for optimizing resource allocation and ensuring equitable and cost-effective care. Future research should focus on these areas to inform better health policies.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 3","pages":"Article 101020"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143943148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficiency and equity of elderly care service resource allocation in China, 2014–2022 2014-2022年中国养老服务资源配置效率与公平性研究
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-06-01 Epub Date: 2025-04-15 DOI: 10.1016/j.hlpt.2025.101016
Min Bao , Rongji Ma , Jianqian Chao

Backgrounds

As the aging process in China progresses, the importance and urgency of the appropriate allocation of elderly care service resources are becoming increasingly prominent. This study aims to provide a multidimensional analysis of the efficiency and equity of elderly care resource allocation in China from 2014 to 2022.

Methods

Three-stage data envelopment analysis was used to measure efficiency, while Bayesian linear regression and spatial correlation tests were employed to explore the influencing factors and spatial effects of efficiency. The Dagum Gini coefficient decomposition method was applied to assess equity and examine the sources of disparities.

Results

From 2014 to 2022, the average efficiency of elderly care service allocation in Chinese provinces showed an increasing trend, rising from 0.469 to 0.602. Spatial correlation tests revealed a global positive spatial correlation among provincial efficiency values, with local clustering observed. The allocation of elderly welfare remained inequitable, with inter-regional differences being the main source of disparities. Conversely, the distribution of bed numbers, end-of-year employee counts and elderly care facility areas remained relatively equitable. The allocation of elderly care institutions and facility numbers transitioned from inequity to moderate equity.

Conclusion

From 2014 to 2022, the overall efficiency of elderly care service resource allocation in China was relatively low, with significant inter-provincial differences and evident spatial effects. The allocation of elderly welfare exhibited inequity, primarily due to regional disparities. Policymakers should address the existing regional disparities, strengthen regional cooperation, and scientifically plan the scale and structure of investment in elderly care service resources.
背景随着中国老龄化进程的不断推进,合理配置养老服务资源的重要性和紧迫性日益凸显。本研究旨在对2014 - 2022年中国养老资源配置效率与公平性进行多维分析。方法采用三阶段数据包络分析对效率进行测度,采用贝叶斯线性回归和空间相关检验探讨效率的影响因素和空间效应。运用达格姆基尼系数分解法对公平性进行评估,考察差异的来源。结果2014 - 2022年,中国各省养老服务配置的平均效率呈上升趋势,从0.469上升到0.602。空间相关检验显示,省际效率值在空间上呈整体正相关,存在局部聚类现象。老年人福利的分配仍然不公平,区域间的差异是差距的主要来源。相反,床位数量、年终雇员人数和老年护理设施面积的分布仍然相对公平。养老机构和设施数量的分配从不公平过渡到适度公平。结论2014 - 2022年,中国养老服务资源配置整体效率较低,省际差异显著,空间效应明显。老年人福利分配不公平,主要是由于地区差异造成的。政策制定者应解决存在的区域差异,加强区域合作,科学规划养老服务资源投资规模和结构。
{"title":"Efficiency and equity of elderly care service resource allocation in China, 2014–2022","authors":"Min Bao ,&nbsp;Rongji Ma ,&nbsp;Jianqian Chao","doi":"10.1016/j.hlpt.2025.101016","DOIUrl":"10.1016/j.hlpt.2025.101016","url":null,"abstract":"<div><h3>Backgrounds</h3><div>As the aging process in China progresses, the importance and urgency of the appropriate allocation of elderly care service resources are becoming increasingly prominent. This study aims to provide a multidimensional analysis of the efficiency and equity of elderly care resource allocation in China from 2014 to 2022.</div></div><div><h3>Methods</h3><div>Three-stage data envelopment analysis was used to measure efficiency, while Bayesian linear regression and spatial correlation tests were employed to explore the influencing factors and spatial effects of efficiency. The Dagum Gini coefficient decomposition method was applied to assess equity and examine the sources of disparities.</div></div><div><h3>Results</h3><div>From 2014 to 2022, the average efficiency of elderly care service allocation in Chinese provinces showed an increasing trend, rising from 0.469 to 0.602. Spatial correlation tests revealed a global positive spatial correlation among provincial efficiency values, with local clustering observed. The allocation of elderly welfare remained inequitable, with inter-regional differences being the main source of disparities. Conversely, the distribution of bed numbers, end-of-year employee counts and elderly care facility areas remained relatively equitable. The allocation of elderly care institutions and facility numbers transitioned from inequity to moderate equity.</div></div><div><h3>Conclusion</h3><div>From 2014 to 2022, the overall efficiency of elderly care service resource allocation in China was relatively low, with significant inter-provincial differences and evident spatial effects. The allocation of elderly welfare exhibited inequity, primarily due to regional disparities. Policymakers should address the existing regional disparities, strengthen regional cooperation, and scientifically plan the scale and structure of investment in elderly care service resources.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 3","pages":"Article 101016"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143887415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting the utilization of healthcare services during COVID-19 - forecasting models based on routine data 预测COVID-19期间医疗保健服务的利用——基于常规数据的预测模型
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-06-01 Epub Date: 2025-05-11 DOI: 10.1016/j.hlpt.2025.101030
Marco Alibone, Marion Ludwig, Christina Simantiri, Josephine Jacob, Dirk Enders

Background

The COVID-19 pandemic has significantly impacted global healthcare systems through the prioritisation of COVID-19 cases and the reallocation of resources, leading, for example, to a postponement of elective procedures. This study quantifies the impact of the COVID-19 pandemic on healthcare utilization in 2020 and 2021.

Methods

Forecasting models were trained using data from the pre-pandemic years 2013 to 2019. The most suitable model was used to predict a trend in healthcare utilization unaffected by the pandemic in the two pandemic years. Deviations between observed and predicted utilization were interpreted as the pandemic impact on healthcare.

Results

During the COVID-19 pandemic, all-cause hospitalizations declined across the first three waves. The first drop occurred in April 2020, with hospitalization rates falling to 1.7 times below expected pre-pandemic levels. A second drop began in November 2020, reaching 1.4 times below expected levels by January 2021. Hospitalizations returned to pre-pandemic levels after strict lockdown measures eased. These declines affected elective procedures but also life-threatening conditions, such as myocardial infarctions (MI). In March and April 2020, admissions for these events were 1.29 times below expected levels. By July 2020, however, MI hospitalization increased, reaching 0.87 times higher than typical pre-pandemic rates.

Discussion

We investigate for the first time the impact of the pandemic on healthcare in Germany using modern forecasting methods showing delayed hospitalizations for acute conditions like MI. Findings highlight the need to protect vulnerable groups and underscore the importance of further research on long-term health impacts and improved public health responses.

Lay summary

The COVID-19 pandemic has significantly disrupted healthcare provision by prioritising COVID-19 cases over other conditions, leading to postponement of interventions and reduced care for serious problems such as myocardial infarctions (MI). This study examined healthcare utilization in Germany in 2020–2021 by comparing observed hospitalisations with predicted values based on pre-pandemic trends from 2013–2019. The results showed a sharp decline in hospitalisations during the first three pandemic waves. In April 2020, hospital admissions fell to almost half the expected level, with a second decline at the end of 2020. Normalisation only set in when the lockdown measures were lifted. Crucially, admissions for life-threatening conditions such as MI also fell temporarily, showing a time lag in hospital admissions. This analysis emphasises the importance of ensuring access to healthcare for critical illnesses, even in times of pandemic, to reduce negative health impacts and improve the resilience of healthcare in future crises.
COVID-19大流行通过对COVID-19病例的优先排序和资源的重新分配,例如导致选择性程序的推迟,对全球卫生保健系统产生了重大影响。本研究量化了2020年和2021年COVID-19大流行对医疗保健利用的影响。方法使用2013年至2019年大流行前的数据对预测模型进行训练。使用最合适的模型来预测两个大流行年份中不受大流行影响的医疗保健利用趋势。观察到的利用率与预测的利用率之间的偏差被解释为大流行对医疗保健的影响。结果在COVID-19大流行期间,前三波全因住院率下降。第一次下降发生在2020年4月,住院率降至大流行前预期水平的1.7倍。第二次下降始于2020年11月,到2021年1月比预期水平低1.4倍。在严格的封锁措施放松后,住院率恢复到大流行前的水平。这些下降不仅影响选择性手术,也影响危及生命的疾病,如心肌梗死(MI)。2020年3月和4月,这些活动的入场人数比预期水平低1.29倍。然而,到2020年7月,心肌梗死住院率增加,达到大流行前典型住院率的0.87倍。我们首次使用现代预测方法调查了大流行对德国医疗保健的影响,该方法显示了心肌梗死等急性疾病的延迟住院。研究结果强调了保护弱势群体的必要性,并强调了进一步研究长期健康影响和改善公共卫生反应的重要性。COVID-19大流行将COVID-19病例置于其他疾病之上,严重扰乱了医疗保健服务,导致干预措施推迟,并减少了对心肌梗死等严重问题的护理。本研究通过比较观察到的住院情况与基于2013-2019年大流行前趋势的预测值,调查了2020-2021年德国的医疗保健利用情况。结果显示,在前三波大流行期间,住院人数急剧下降。2020年4月,住院人数降至预期水平的近一半,并在2020年底出现第二次下降。只有在封锁措施解除后,关系才开始正常化。至关重要的是,因心肌梗塞等危及生命的疾病入院的人数也暂时下降,显示出住院人数的时间差。这一分析强调,即使在大流行时期,也必须确保重症患者获得医疗保健,以减少对健康的负面影响,并提高医疗保健在未来危机中的复原力。
{"title":"Predicting the utilization of healthcare services during COVID-19 - forecasting models based on routine data","authors":"Marco Alibone,&nbsp;Marion Ludwig,&nbsp;Christina Simantiri,&nbsp;Josephine Jacob,&nbsp;Dirk Enders","doi":"10.1016/j.hlpt.2025.101030","DOIUrl":"10.1016/j.hlpt.2025.101030","url":null,"abstract":"<div><h3>Background</h3><div>The COVID-19 pandemic has significantly impacted global healthcare systems through the prioritisation of COVID-19 cases and the reallocation of resources, leading, for example, to a postponement of elective procedures. This study quantifies the impact of the COVID-19 pandemic on healthcare utilization in 2020 and 2021.</div></div><div><h3>Methods</h3><div>Forecasting models were trained using data from the pre-pandemic years 2013 to 2019. The most suitable model was used to predict a trend in healthcare utilization unaffected by the pandemic in the two pandemic years. Deviations between observed and predicted utilization were interpreted as the pandemic impact on healthcare.</div></div><div><h3>Results</h3><div>During the COVID-19 pandemic, all-cause hospitalizations declined across the first three waves. The first drop occurred in April 2020, with hospitalization rates falling to 1.7 times below expected pre-pandemic levels. A second drop began in November 2020, reaching 1.4 times below expected levels by January 2021. Hospitalizations returned to pre-pandemic levels after strict lockdown measures eased. These declines affected elective procedures but also life-threatening conditions, such as myocardial infarctions (MI). In March and April 2020, admissions for these events were 1.29 times below expected levels. By July 2020, however, MI hospitalization increased, reaching 0.87 times higher than typical pre-pandemic rates.</div></div><div><h3>Discussion</h3><div>We investigate for the first time the impact of the pandemic on healthcare in Germany using modern forecasting methods showing delayed hospitalizations for acute conditions like MI. Findings highlight the need to protect vulnerable groups and underscore the importance of further research on long-term health impacts and improved public health responses.</div></div><div><h3>Lay summary</h3><div>The COVID-19 pandemic has significantly disrupted healthcare provision by prioritising COVID-19 cases over other conditions, leading to postponement of interventions and reduced care for serious problems such as myocardial infarctions (MI). This study examined healthcare utilization in Germany in 2020–2021 by comparing observed hospitalisations with predicted values based on pre-pandemic trends from 2013–2019. The results showed a sharp decline in hospitalisations during the first three pandemic waves. In April 2020, hospital admissions fell to almost half the expected level, with a second decline at the end of 2020. Normalisation only set in when the lockdown measures were lifted. Crucially, admissions for life-threatening conditions such as MI also fell temporarily, showing a time lag in hospital admissions. This analysis emphasises the importance of ensuring access to healthcare for critical illnesses, even in times of pandemic, to reduce negative health impacts and improve the resilience of healthcare in future crises.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 3","pages":"Article 101030"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144070962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Musculoskeletal complaints following hospitalization for COVID-19 infection 因COVID-19感染住院后的肌肉骨骼疾病
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-06-01 Epub Date: 2025-04-08 DOI: 10.1016/j.hlpt.2025.101012
Mike Ruettermann , Jan Peters , Alexander Kaltenborn , Andre Gutcke , Martin Bergold , Oliver Pieske

Objectives

The term post- or long-COVID syndrome describes >50 possible long-term effects on various organ systems following COVID-19 infection. The pathophysiology of most symptoms remains unclear, and the time course of symptom onset varies widely.

Methods

Using a telephone survey and validated questionnaires we investigated the incidence of musculoskeletal complaints after inpatient treatment for COVID-19 infection compared with patients hospitalized for a non-COVID diagnosis.

Results

112 patients were followed up for least 6 months after discharge (range 6–21 months). Hospitalized and ICU-treated COVID patients showed significant changes in WOMAC scores for the lower extremities (Kruskal-Wallis test, p = 0.005). There is also a significant change in the post-discharge question about new limb complaints (Chi-squared test, p = 0.005), regardless of whether the patients received intensive care or not. The majority of COVID patients with joint or muscle symptoms describe them as widespread and much less frequently as localized and restricted to one region.

Conclusions

In addition to the already known long-term effects, there is evidence that patients with COVID who have been treated in an inpatient setting may also suffer from long-term musculoskeletal effects. Women of working age are particularly affected by the resulting limitations.
“后或长期covid综合征”一词描述了COVID-19感染后对各器官系统可能产生的50种长期影响。大多数症状的病理生理尚不清楚,症状发作的时间过程差异很大。方法采用电话调查和有效问卷调查的方式,对因COVID-19感染住院治疗后的肌肉骨骼疾病发生率与因非COVID-19诊断住院的患者进行比较。结果112例患者出院后至少随访6个月(6 ~ 21个月)。住院和icu治疗的患者下肢WOMAC评分有显著变化(Kruskal-Wallis检验,p = 0.005)。无论患者是否接受重症监护,出院后关于新肢体主诉的问题也有显著变化(χ 2检验,p = 0.005)。大多数出现关节或肌肉症状的COVID - 19患者将其描述为广泛存在,而很少出现局部和局限于一个区域的情况。结论除了已知的长期影响外,有证据表明,在住院环境中接受治疗的COVID患者还可能遭受长期的肌肉骨骼影响。工作年龄的妇女特别受到由此产生的限制的影响。
{"title":"Musculoskeletal complaints following hospitalization for COVID-19 infection","authors":"Mike Ruettermann ,&nbsp;Jan Peters ,&nbsp;Alexander Kaltenborn ,&nbsp;Andre Gutcke ,&nbsp;Martin Bergold ,&nbsp;Oliver Pieske","doi":"10.1016/j.hlpt.2025.101012","DOIUrl":"10.1016/j.hlpt.2025.101012","url":null,"abstract":"<div><h3>Objectives</h3><div>The term post- or long-COVID syndrome describes &gt;50 possible long-term effects on various organ systems following COVID-19 infection. The pathophysiology of most symptoms remains unclear, and the time course of symptom onset varies widely.</div></div><div><h3>Methods</h3><div>Using a telephone survey and validated questionnaires we investigated the incidence of musculoskeletal complaints after inpatient treatment for COVID-19 infection compared with patients hospitalized for a non-COVID diagnosis.</div></div><div><h3>Results</h3><div>112 patients were followed up for least 6 months after discharge (range 6–21 months). Hospitalized and ICU-treated COVID patients showed significant changes in WOMAC scores for the lower extremities (Kruskal-Wallis test, <em>p</em> = 0.005). There is also a significant change in the post-discharge question about new limb complaints (Chi-squared test, <em>p</em> = 0.005), regardless of whether the patients received intensive care or not. The majority of COVID patients with joint or muscle symptoms describe them as widespread and much less frequently as localized and restricted to one region.</div></div><div><h3>Conclusions</h3><div>In addition to the already known long-term effects, there is evidence that patients with COVID who have been treated in an inpatient setting may also suffer from long-term musculoskeletal effects. Women of working age are particularly affected by the resulting limitations.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 3","pages":"Article 101012"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144070961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-effectiveness, use and implementation of telehealth solutions for CHF and COPD: A systematic review using the PRISMA method 慢性心力衰竭和慢性阻塞性肺病远程医疗解决方案的成本效益、使用和实施:使用PRISMA方法的系统审查
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-06-01 Epub Date: 2025-05-02 DOI: 10.1016/j.hlpt.2025.101023
Ofir Ben-Assuli

Background

According to leading health organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), telehealth applications have the potential to improve patients' health, particularly for the billions of patients suffering from chronic diseases such as Congestive Heart Failure (CHF) and Chronic Obstructive Pulmonary Disease (COPD). While telehealth solutions hold promise, there is currently inadequate clinical evidence supporting their use in public health surveillance and home-based care, making it difficult to draw decisive conclusions.

Objective

The objective of this work was to evaluate the cost-effectiveness, use, and implementation of telehealth solutions for patients with chronic diseases, specifically CHF and COPD, through a review of the current literature. This narrative review examined studies presenting cost-effectiveness analyses, use, and implementation of telehealth for these patients.

Methods

This work implemented the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. In order to receive recency and to examine recent and innovative telehealth solutions, articles published in English from 2010 to 2023 were included in the search. The inclusion criteria were papers on telehealth tools employed for CHF and COPD patients that assessed their cost-effectiveness.

Results

The majority of the studies were conducted in Europe. Approximately half had an adequate sample size and tracked patients prospectively for a sufficient duration. The most frequently used telehealth method was distance monitoring, with only a few studies incorporating home visits or phone calls. The parameters monitored included blood pressure, oxygen saturation, heart rate, and spirometry, among others. General statistical analyses and regression models were the most frequently used methods, although several studies incorporated Markov models and simulations.

Discussion

The majority of the papers (20 out of 26) concluded that the tools implemented led to either cost-effectiveness, cost-savings or strongly dominance. This promising result shows that telehealth is an important topic that deserves further research on its effectiveness as well as cost-effectiveness for chronic disease management.

Limitations

One key limitation of this PRISMA review is that the literature search was restricted to two major diseases, and the language of the publications was exclusively English. Thus, the generalizability of the findings to other chronic diseases is subject to caution.
世界卫生组织(世卫组织)和疾病控制和预防中心(疾控中心)等主要卫生组织认为,远程保健应用有可能改善患者的健康,特别是数十亿患有充血性心力衰竭(CHF)和慢性阻塞性肺病(COPD)等慢性病的患者。虽然远程保健解决方案大有希望,但目前支持其用于公共卫生监测和家庭护理的临床证据不足,因此难以得出决定性结论。本研究的目的是通过对现有文献的回顾,评估慢性病患者,特别是慢性心力衰竭和慢性阻塞性肺病患者远程医疗解决方案的成本效益、使用和实施情况。这篇叙述性综述审查了介绍这些患者远程医疗的成本效益分析、使用和实施的研究。方法本研究实施了系统评价和荟萃分析指南的首选报告项目。为了接收最新的和审查最新的和创新的远程保健解决方案,检索中包括了2010年至2023年以英文发表的文章。纳入标准是关于用于慢性心力衰竭和慢性阻塞性肺病患者的远程医疗工具的论文,评估其成本效益。结果大多数研究是在欧洲进行的。大约一半的研究有足够的样本量,并对患者进行了足够的随访。最常用的远程保健方法是远程监测,只有少数研究纳入了家访或电话。监测的参数包括血压、血氧饱和度、心率和肺活量测定等。一般统计分析和回归模型是最常用的方法,尽管一些研究结合了马尔可夫模型和模拟。大多数论文(26篇中的20篇)得出结论,实施的工具要么导致成本效益,要么导致成本节约,要么导致强大的主导地位。这一有希望的结果表明,远程保健是一个重要的主题,值得进一步研究其对慢性病管理的有效性和成本效益。局限性本次PRISMA综述的一个关键局限性是文献检索仅限于两种主要疾病,并且出版物的语言完全是英语。因此,将研究结果推广到其他慢性疾病需要谨慎。
{"title":"Cost-effectiveness, use and implementation of telehealth solutions for CHF and COPD: A systematic review using the PRISMA method","authors":"Ofir Ben-Assuli","doi":"10.1016/j.hlpt.2025.101023","DOIUrl":"10.1016/j.hlpt.2025.101023","url":null,"abstract":"<div><h3>Background</h3><div>According to leading health organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), telehealth applications have the potential to improve patients' health, particularly for the billions of patients suffering from chronic diseases such as Congestive Heart Failure (CHF) and Chronic Obstructive Pulmonary Disease (COPD). While telehealth solutions hold promise, there is currently inadequate clinical evidence supporting their use in public health surveillance and home-based care, making it difficult to draw decisive conclusions.</div></div><div><h3>Objective</h3><div>The objective of this work was to evaluate the cost-effectiveness, use, and implementation of telehealth solutions for patients with chronic diseases, specifically CHF and COPD, through a review of the current literature. This narrative review examined studies presenting cost-effectiveness analyses, use, and implementation of telehealth for these patients.</div></div><div><h3>Methods</h3><div>This work implemented the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. In order to receive recency and to examine recent and innovative telehealth solutions, articles published in English from 2010 to 2023 were included in the search. The inclusion criteria were papers on telehealth tools employed for CHF and COPD patients that assessed their cost-effectiveness.</div></div><div><h3>Results</h3><div>The majority of the studies were conducted in Europe. Approximately half had an adequate sample size and tracked patients prospectively for a sufficient duration. The most frequently used telehealth method was distance monitoring, with only a few studies incorporating home visits or phone calls. The parameters monitored included blood pressure, oxygen saturation, heart rate, and spirometry, among others. General statistical analyses and regression models were the most frequently used methods, although several studies incorporated Markov models and simulations.</div></div><div><h3>Discussion</h3><div>The majority of the papers (20 out of 26) concluded that the tools implemented led to either cost-effectiveness, cost-savings or strongly dominance. This promising result shows that telehealth is an important topic that deserves further research on its effectiveness as well as cost-effectiveness for chronic disease management.</div></div><div><h3>Limitations</h3><div>One key limitation of this PRISMA review is that the literature search was restricted to two major diseases, and the language of the publications was exclusively English. Thus, the generalizability of the findings to other chronic diseases is subject to caution.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 3","pages":"Article 101023"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143936687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Young people’s perspective on technology-enabled personalised youth mental health care for depression in the UK 年轻人对英国抑郁症的技术个性化青少年心理健康护理的看法
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-06-01 Epub Date: 2025-05-13 DOI: 10.1016/j.hlpt.2025.101028
Vilas Sawrikar , Kyle Buchan , Karri Gillespie-Smith

Objectives

While new models of youth mental health care will be introduced in the United Kingdom (UK) as part of the NHS’s Long Term Plan, little is known about how to design and implement these models for depression. This study investigated young people’s perspective on the key attributes of technology-enabled personalised youth mental health care for depression to ensure the crucial components are implemented.

Methods

Qualitative data of young people’s perspectives was collected over two phases. In phase 1, 37 young people participated in interviews where they were presented with two depression vignettes differentiated by clinical stage and asked to outline the key attributes of care. In phase 2, 8 young people participated in a group workshop co-designing digital care pathways. Recordings were analysed thematically to identify key service, model, and digitised care attributes.

Results

Key service attributes emphasised youth-friendly, welcoming environments allowing for timely access to care. Key model attributes included needs-led care, supported by youth and family engagement, personalised care planning, care coordination, monitoring, and peer support. Key attributes of digitised care included facilitating access to care, centralised assessments, patient decision aid, monitoring, and design principles of flexibility and human assistance.

Conclusions

The results suggest that evidence-informed methods of delivering care based on individual needs is critical to personalised care and that the implementation of this model entails specific configuration of highly personalised and measurement-based capabilities within youth mental health services. In line with this, a digitised care pathway for delivering personalised care for depression is presented.

Public interest summary

Personalised care reforms in the United Kingdom (UK) will see the implementation of technology-enabled, youth specific models of care supported by emerging health technologies. An analysis of young people’s perspective of these models indicated that delivery of technology-enabled personalised youth mental health care can be defined in terms of service characteristics, service model, and digitised care pathways. Young people propose that services should be youth friendly and easy to access, while care should be tailored to individual needs and preferences. Treatments should also be organised on as needed bases with youth having greater choice. Digitised care pathways were proposed to help reduce barriers to care and streamline pathways from screening to referrals, assessments and transfers between services. The results are used to prototype a digitised care pathway for delivering personalised care for depression within youth mental health services in the UK.
作为英国国家医疗服务体系(NHS)长期计划的一部分,英国将引入青少年心理健康保健的新模式,但人们对如何设计和实施这些抑郁症模式知之甚少。这项研究调查了年轻人对技术支持的个性化青少年抑郁症心理健康护理的关键属性的看法,以确保关键组成部分得到实施。方法分两个阶段收集青少年视角的定性数据。在第1阶段,37名年轻人参加了访谈,在访谈中,他们看到了根据临床阶段区分的两个抑郁症小插曲,并被要求概述护理的关键属性。在第二阶段,8名年轻人参加了一个小组研讨会,共同设计数字护理途径。对记录进行主题分析,以确定关键服务、模型和数字化护理属性。结果主要服务属性强调青年友好、友好的环境,允许及时获得护理。关键的模式属性包括以需求为导向的护理,由青年和家庭参与支持,个性化护理计划,护理协调,监测和同伴支持。数字化护理的关键属性包括便利获得护理、集中评估、患者决策辅助、监测以及灵活性和人力援助的设计原则。结论:研究结果表明,基于个人需求提供护理的循证方法对个性化护理至关重要,该模式的实施需要在青少年心理健康服务中具体配置高度个性化和基于测量的能力。与此相一致,提出了一种为抑郁症提供个性化护理的数字化护理途径。公共利益摘要英国的个性化护理改革将在新兴卫生技术的支持下实施技术支持的、针对青年的护理模式。对年轻人对这些模式的看法的分析表明,技术支持的个性化青少年精神卫生保健的提供可以从服务特征、服务模式和数字化护理途径方面进行定义。年轻人建议,服务应对青年友好,易于获得,而护理应根据个人需要和偏好量身定制。治疗也应该根据需要组织起来,让年轻人有更多的选择。提出了数字化护理途径,以帮助减少护理障碍,并简化从筛查到转诊、评估和服务之间转移的途径。研究结果被用于英国青少年心理健康服务中提供个性化抑郁症护理的数字化护理途径的原型。
{"title":"Young people’s perspective on technology-enabled personalised youth mental health care for depression in the UK","authors":"Vilas Sawrikar ,&nbsp;Kyle Buchan ,&nbsp;Karri Gillespie-Smith","doi":"10.1016/j.hlpt.2025.101028","DOIUrl":"10.1016/j.hlpt.2025.101028","url":null,"abstract":"<div><h3>Objectives</h3><div>While new models of youth mental health care will be introduced in the United Kingdom (UK) as part of the NHS’s Long Term Plan, little is known about how to design and implement these models for depression. This study investigated young people’s perspective on the key attributes of technology-enabled personalised youth mental health care for depression to ensure the crucial components are implemented.</div></div><div><h3>Methods</h3><div>Qualitative data of young people’s perspectives was collected over two phases. In phase 1, 37 young people participated in interviews where they were presented with two depression vignettes differentiated by clinical stage and asked to outline the key attributes of care. In phase 2, 8 young people participated in a group workshop co-designing digital care pathways. Recordings were analysed thematically to identify key service, model, and digitised care attributes.</div></div><div><h3>Results</h3><div>Key service attributes emphasised youth-friendly, welcoming environments allowing for timely access to care. Key model attributes included needs-led care, supported by youth and family engagement, personalised care planning, care coordination, monitoring, and peer support. Key attributes of digitised care included facilitating access to care, centralised assessments, patient decision aid, monitoring, and design principles of flexibility and human assistance.</div></div><div><h3>Conclusions</h3><div>The results suggest that evidence-informed methods of delivering care based on individual needs is critical to personalised care and that the implementation of this model entails specific configuration of highly personalised and measurement-based capabilities within youth mental health services. In line with this, a digitised care pathway for delivering personalised care for depression is presented.</div></div><div><h3>Public interest summary</h3><div>Personalised care reforms in the United Kingdom (UK) will see the implementation of technology-enabled, youth specific models of care supported by emerging health technologies. An analysis of young people’s perspective of these models indicated that delivery of technology-enabled personalised youth mental health care can be defined in terms of service characteristics, service model, and digitised care pathways. Young people propose that services should be youth friendly and easy to access, while care should be tailored to individual needs and preferences. Treatments should also be organised on as needed bases with youth having greater choice. Digitised care pathways were proposed to help reduce barriers to care and streamline pathways from screening to referrals, assessments and transfers between services. The results are used to prototype a digitised care pathway for delivering personalised care for depression within youth mental health services in the UK.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 3","pages":"Article 101028"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144124373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Appropriateness of the percutaneous coronary intervention technical fee in Japan 日本经皮冠状动脉介入治疗技术费用的适宜性
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-06-01 Epub Date: 2025-05-03 DOI: 10.1016/j.hlpt.2025.101026
Satoru Hashimoto , Yoshihiro Motozawa , Burt Cohen , Toshiki Mano

Objectives

In Japan, reimbursements of technical fees for percutaneous coronary intervention (PCI) are not considered to reflect actual medical costs, since medical procedures frequently cost hospitals more than they make. This study evaluated the appropriateness of PCI technical fees in Japan as part of reimbursed medical fees.

Methods

We estimated the PCI technical fee’s validity from three approaches including 1) costing calculation, 2) survey-based cost estimation, and 3) lost profit methods.

Results

For the costing calculation method, we used the draft proposal that is evaluated by the Japanese Health Insurance Federation for Surgery (Gaihoren draft proposal). The proposal indicated PCI technical fees of ¥727,997 for acute myocardial infarction (AMI) and ¥596,397 for unstable angina (UA). For the survey-based cost estimation method, a survey of cardiologists showed the appropriateness of ¥814,600 and ¥554,825 for AMI-PCI and UA-PCI, respectively, while the lost profit method evaluated AMI-PCI at ¥812,210 and UA-PCI at ¥773,961. The average costs of technical fees calculated according to the three approaches were ¥772,186 for AMI-PCI and ¥566,688 for UA-PCI, which are higher than the existing reimbursements of ¥343,800 and ¥243,800, respectively.

Conclusion

The present study showed that technical fees for PCI did not reflect estimated costs in three approaches. The majority of hospitals in Japan are operating at a loss for medical profit, and these results call into question, the need for a review of the healthcare costs reimbursed by the government.

Lay summary

In Japan, reimbursement prices of percutaneous coronary intervention (PCI) technical fees are considered to be lower than the actual cost, which can translate to losses for hospitals, especially when complex PCI procedures are performed. We estimated the appropriateness of technical fees using three approaches including 1) costing calculation, 2) survey-based cost estimation, and 3) lost profit methods. The results confirmed that technical fees, which form the core of medical fees, do not reflect estimated costs. It was suggested that this discrepancy has led to a deficit in the structure of Japanese hospitals.
目的在日本,经皮冠状动脉介入治疗(PCI)的技术费用报销不被认为反映了实际的医疗成本,因为医疗程序的成本经常高于医院的收入。本研究评估了日本将PCI技术费用作为报销医疗费用的一部分的适宜性。方法采用成本计算法、基于调查的成本估算法和亏损利润法对PCI技术费用的有效性进行评估。结果成本计算方法采用日本外科健康保险联合会评估的提案草案(Gaihoren草案)。建议急性心肌梗死(AMI) PCI技术费用为727997元,不稳定型心绞痛(UA) PCI技术费用为596397元。对于基于调查的成本估算法,对心脏病专家的调查显示AMI-PCI和UA-PCI的适宜性分别为814,600元和554,825元,而亏损利润法对AMI-PCI和UA-PCI的适宜性分别为812,210元和773,961元。三种方法计算的技术费用平均成本分别为AMI-PCI 772,186元、UA-PCI 566,688元,高于现有的报销金额343,800元、243,800元。结论本研究显示PCI的技术费用不能反映三种方法的估计成本。日本的大多数医院在医疗利润方面都处于亏损状态,这些结果令人质疑,是否有必要对政府报销的医疗费用进行审查。在日本,经皮冠状动脉介入治疗(PCI)技术费用的报销价格被认为低于实际成本,这可能转化为医院的损失,特别是在进行复杂的PCI手术时。我们使用三种方法来评估技术费用的适当性,包括1)成本计算,2)基于调查的成本估算和3)损失利润法。结果证实,构成医疗费用核心的技术费用没有反映估计费用。有人认为,这种差异导致了日本医院结构的赤字。
{"title":"Appropriateness of the percutaneous coronary intervention technical fee in Japan","authors":"Satoru Hashimoto ,&nbsp;Yoshihiro Motozawa ,&nbsp;Burt Cohen ,&nbsp;Toshiki Mano","doi":"10.1016/j.hlpt.2025.101026","DOIUrl":"10.1016/j.hlpt.2025.101026","url":null,"abstract":"<div><h3>Objectives</h3><div>In Japan, reimbursements of technical fees for percutaneous coronary intervention (PCI) are not considered to reflect actual medical costs, since medical procedures frequently cost hospitals more than they make. This study evaluated the appropriateness of PCI technical fees in Japan as part of reimbursed medical fees.</div></div><div><h3>Methods</h3><div>We estimated the PCI technical fee’s validity from three approaches including 1) costing calculation, 2) survey-based cost estimation, and 3) lost profit methods.</div></div><div><h3>Results</h3><div>For the costing calculation method, we used the draft proposal that is evaluated by the Japanese Health Insurance Federation for Surgery (Gaihoren draft proposal). The proposal indicated PCI technical fees of ¥727,997 for acute myocardial infarction (AMI) and ¥596,397 for unstable angina (UA). For the survey-based cost estimation method, a survey of cardiologists showed the appropriateness of ¥814,600 and ¥554,825 for AMI-PCI and UA-PCI, respectively, while the lost profit method evaluated AMI-PCI at ¥812,210 and UA-PCI at ¥773,961. The average costs of technical fees calculated according to the three approaches were ¥772,186 for AMI-PCI and ¥566,688 for UA-PCI, which are higher than the existing reimbursements of ¥343,800 and ¥243,800, respectively.</div></div><div><h3>Conclusion</h3><div>The present study showed that technical fees for PCI did not reflect estimated costs in three approaches. The majority of hospitals in Japan are operating at a loss for medical profit, and these results call into question, the need for a review of the healthcare costs reimbursed by the government.</div></div><div><h3>Lay summary</h3><div>In Japan, reimbursement prices of percutaneous coronary intervention (PCI) technical fees are considered to be lower than the actual cost, which can translate to losses for hospitals, especially when complex PCI procedures are performed. We estimated the appropriateness of technical fees using three approaches including 1) costing calculation, 2) survey-based cost estimation, and 3) lost profit methods. The results confirmed that technical fees, which form the core of medical fees, do not reflect estimated costs. It was suggested that this discrepancy has led to a deficit in the structure of Japanese hospitals.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 3","pages":"Article 101026"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143929474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overcoming vaccine hesitancy: Evidence from Italy during the COVID-19 pandemic 克服疫苗犹豫不决:COVID-19 大流行期间来自意大利的证据
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-06-01 Epub Date: 2025-03-06 DOI: 10.1016/j.hlpt.2025.100996
Alessandro Del Ponte , Audrey De Dominicis , Paolo Canofari

Objectives

Here we investigate whether releasing COVID-19 vaccines at open-day events boosted Italy's vaccination campaign in 2021. This strategy exploits insights from psychology.

Study design

We built an original dataset covering 200 days of vaccination data in Italy, including “open day” events. Open-day events (in short: open days) are instances where COVID-19 vaccines were released only for a specific day at a specified location (usually, a large pavilion or a public building). Importantly, releasing vaccines through open days instead of the usual appointment channel leaves the supply of vaccines unaltered. Our dependent variables are the number of total and first doses administered in proportion to the eligible population. Our key independent variable is the presence of open-day events in a given region on a specific day.

Methods

We analyzed the data using regression with fixed effects for time and region. The analysis was robust to alternative model specifications.

Results

We find that when an open day event was organized, in proportion to the eligible population, there was an average 0.39–0.44 percentage point increase in total doses administered and a 0.30–0.33 percentage point increase in first doses administered. These figures correspond to an average increase of 10,455–11,796 in total doses administered and 8,043–8,847 in the first doses administered.

Conclusions

Releasing vaccines by organizing open-day events was associated with an increase in COVID-19 vaccinations in most Italian regions. These results call for further study of the effectiveness of open days to increase vaccinations and protect against other infectious diseases or future pandemics.
在这里,我们调查在开放日活动中发布COVID-19疫苗是否促进了2021年意大利的疫苗接种运动。这种策略利用了心理学的洞察力。研究设计我们建立了一个原始数据集,涵盖意大利200天的疫苗接种数据,包括“开放日”活动。开放日活动(简而言之:开放日)是指仅在特定日期在特定地点(通常是大型展馆或公共建筑)发放COVID-19疫苗的情况。重要的是,通过开放日而不是通常的预约渠道发放疫苗,使疫苗供应保持不变。我们的因变量是总剂量和首次剂量与符合条件的人群的比例。我们的关键自变量是某一特定日期某一地区是否有开放日活动。方法采用时间和区域固定效应的回归分析方法。该分析对可选模型规范具有鲁棒性。结果我们发现,当组织开放日活动时,按符合条件的人群比例,总剂量平均增加0.39-0.44个百分点,首次剂量平均增加0.30-0.33个百分点。这些数字相当于总剂量平均增加10 455 - 11 796剂,第一次剂量平均增加8 043 - 8 847剂。在意大利大多数地区,通过组织开放日活动发放疫苗与COVID-19疫苗接种的增加有关。这些结果要求进一步研究开放日的有效性,以增加疫苗接种和预防其他传染病或未来的大流行病。
{"title":"Overcoming vaccine hesitancy: Evidence from Italy during the COVID-19 pandemic","authors":"Alessandro Del Ponte ,&nbsp;Audrey De Dominicis ,&nbsp;Paolo Canofari","doi":"10.1016/j.hlpt.2025.100996","DOIUrl":"10.1016/j.hlpt.2025.100996","url":null,"abstract":"<div><h3>Objectives</h3><div>Here we investigate whether releasing COVID-19 vaccines at open-day events boosted Italy's vaccination campaign in 2021. This strategy exploits insights from psychology.</div></div><div><h3>Study design</h3><div>We built an original dataset covering 200 days of vaccination data in Italy, including “open day” events. Open-day events (in short: open days) are instances where COVID-19 vaccines were released only for a specific day at a specified location (usually, a large pavilion or a public building). Importantly, releasing vaccines through open days instead of the usual appointment channel leaves the supply of vaccines unaltered. Our dependent variables are the number of total and first doses administered in proportion to the eligible population. Our key independent variable is the presence of open-day events in a given region on a specific day.</div></div><div><h3>Methods</h3><div>We analyzed the data using regression with fixed effects for time and region. The analysis was robust to alternative model specifications.</div></div><div><h3>Results</h3><div>We find that when an open day event was organized, in proportion to the eligible population, there was an average 0.39–0.44 percentage point increase in total doses administered and a 0.30–0.33 percentage point increase in first doses administered. These figures correspond to an average increase of 10,455–11,796 in total doses administered and 8,043–8,847 in the first doses administered.</div></div><div><h3>Conclusions</h3><div>Releasing vaccines by organizing open-day events was associated with an increase in COVID-19 vaccinations in most Italian regions. These results call for further study of the effectiveness of open days to increase vaccinations and protect against other infectious diseases or future pandemics.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 3","pages":"Article 100996"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143593430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementing a clinical decision support system in an Aboriginal health service – A qualitative case study 在原住民健康服务中实施临床决策支持系统-定性案例研究
IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2025-06-01 Epub Date: 2025-04-05 DOI: 10.1016/j.hlpt.2025.101010
Sophie Pascoe , Debbie-Ann Gillon , Paul Kamler , Asanga Abeyaratne , Natasha Pavlin , Gillian Gorham

Objective

This qualitative case study aims to evaluate the implementation of a clinical decision support system (CDSS) – Territory Kidney Care (TKC) – at an Aboriginal health service in the Northern Territory (NT) of Australia. This research aims to contribute understandings about the challenges clinicians face when navigating electronic systems within an Aboriginal health service setting and enablers and barriers to the implementation of CDSS.

Methods

Within a larger evaluation of TKC, this qualitative case study involved 13 baseline semi-structured interviews completed between October 2022 and January 2023 and seven follow up interviews conducted in June 2023. Through purposive sampling, clinicians in a range of primary care roles participated in the study. Interview transcripts were inductively and iteratively coded by two researchers using a thematic analysis approach.

Results

The baseline evaluation found that clinicians working in an Aboriginal health service used multiple electronic health systems, spent considerable time collating patient data across systems and faced challenges related to missing information, technological issues and limited training. The process evaluation of TKC implementation identified that adequate training, a funded Implementation Officer role and supportive leadership were central enablers, while competing clinical priorities, time limitations, staff shortages, access processes were key barriers to uptake and usage.

Conclusions

This case study highlights the need for integrated data tools in Aboriginal health services to bridge the gaps between primary, tertiary, government and non-government services. The evaluation emphasises the importance of embedding CDSS within workflows and ensuring there are dedicated staff and resources to facilitate implementation.

Lay Summary

This study focuses on how a clinical decision support system was implemented in an Aboriginal health service in the Northern Territory of Australia. Through interviews with clinicians, we identify key barriers and enablers to accessing clinical decision support, as an adjunct to electronic health records. Clinicians in Aboriginal health services must use multiple systems and spend a lot of time looking for information about their patients; a new integrated data platform called Territory Kidney Care was implemented to pull information together from different health services. This research highlights the importance of ensuring there are dedicated staff and resources to help implement new systems.
目标本定性案例研究旨在评估澳大利亚北部地区(NT)土著医疗服务机构临床决策支持系统(CDSS)--"地区肾脏护理"(TKC)的实施情况。这项研究旨在帮助人们了解临床医生在土著医疗服务环境中使用电子系统时所面临的挑战,以及实施 CDSS 的有利因素和障碍。方法在对 TKC 进行更大规模评估的过程中,这项定性案例研究在 2022 年 10 月至 2023 年 1 月期间完成了 13 次基线半结构式访谈,并在 2023 年 6 月进行了 7 次后续访谈。通过有目的的抽样,参与研究的临床医生来自不同的基层医疗机构。基线评估发现,在原住民医疗服务机构工作的临床医生使用多个电子医疗系统,花费大量时间整理各系统中的患者数据,并面临信息缺失、技术问题和培训有限等挑战。对 TKC 实施过程的评估发现,充分的培训、有资金支持的实施官员角色和支持性领导是主要的推动因素,而相互竞争的临床优先事项、时间限制、人员短缺和访问流程则是吸收和使用 TKC 的主要障碍。评估强调了将 CDSS 嵌入工作流程并确保有专门的人员和资源来促进实施的重要性。通过对临床医生的访谈,我们发现了临床决策支持作为电子健康记录辅助工具的主要障碍和促进因素。原住民医疗服务机构的临床医生必须使用多个系统,并花费大量时间寻找有关病人的信息;一个名为 "领地肾脏护理"(Territory Kidney Care)的新集成数据平台已经投入使用,以便将不同医疗服务机构的信息整合在一起。这项研究强调了确保有专门的人员和资源来帮助实施新系统的重要性。
{"title":"Implementing a clinical decision support system in an Aboriginal health service – A qualitative case study","authors":"Sophie Pascoe ,&nbsp;Debbie-Ann Gillon ,&nbsp;Paul Kamler ,&nbsp;Asanga Abeyaratne ,&nbsp;Natasha Pavlin ,&nbsp;Gillian Gorham","doi":"10.1016/j.hlpt.2025.101010","DOIUrl":"10.1016/j.hlpt.2025.101010","url":null,"abstract":"<div><h3>Objective</h3><div>This qualitative case study aims to evaluate the implementation of a clinical decision support system (CDSS) – Territory Kidney Care (TKC) – at an Aboriginal health service in the Northern Territory (NT) of Australia. This research aims to contribute understandings about the challenges clinicians face when navigating electronic systems within an Aboriginal health service setting and enablers and barriers to the implementation of CDSS.</div></div><div><h3>Methods</h3><div>Within a larger evaluation of TKC, this qualitative case study involved 13 baseline semi-structured interviews completed between October 2022 and January 2023 and seven follow up interviews conducted in June 2023. Through purposive sampling, clinicians in a range of primary care roles participated in the study. Interview transcripts were inductively and iteratively coded by two researchers using a thematic analysis approach.</div></div><div><h3>Results</h3><div>The baseline evaluation found that clinicians working in an Aboriginal health service used multiple electronic health systems, spent considerable time collating patient data across systems and faced challenges related to missing information, technological issues and limited training. The process evaluation of TKC implementation identified that adequate training, a funded Implementation Officer role and supportive leadership were central enablers, while competing clinical priorities, time limitations, staff shortages, access processes were key barriers to uptake and usage.</div></div><div><h3>Conclusions</h3><div>This case study highlights the need for integrated data tools in Aboriginal health services to bridge the gaps between primary, tertiary, government and non-government services. The evaluation emphasises the importance of embedding CDSS within workflows and ensuring there are dedicated staff and resources to facilitate implementation.</div></div><div><h3>Lay Summary</h3><div>This study focuses on how a clinical decision support system was implemented in an Aboriginal health service in the Northern Territory of Australia. Through interviews with clinicians, we identify key barriers and enablers to accessing clinical decision support, as an adjunct to electronic health records. Clinicians in Aboriginal health services must use multiple systems and spend a lot of time looking for information about their patients; a new integrated data platform called Territory Kidney Care was implemented to pull information together from different health services. This research highlights the importance of ensuring there are dedicated staff and resources to help implement new systems.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 3","pages":"Article 101010"},"PeriodicalIF":3.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143823224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health Policy and Technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1